Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Search

Total 33 results found. Search for [ dr reddys lab ]

Results 1 to 21 of 33
E Kumar Sharma
October 26, 2018
The pharma major had posted a robust performance in the June quarter of FY19, largely aided by the launch in the US of gSuboxone, the generic version of the drug to deal opioid addiction.


PTI
June 4, 2018



BT Online
New Delhi, November 19, 2015
All sectors except healthcare closed the day in the green with strong gains made by financial and IT stocks that were beaten down in the previous session.


BusinessToday.in
New Delhi, October 21, 2015
The S&P BSE Sensex wiped out all its early gaines and fell 19.17 points to end at 27,287.66 as pharma and banking stocks failed to shape up.


BT Online
New Delhi, September 28, 2015
Sun Pharma Advanced Research Co Ltd (SPARC) closed 2.62 per cent down at Rs 375.80 apiece on Monday after USFDA revoked approval for SPARC's seizure drug, citing manufacturing quality problems at its production site.


IANS
New Delhi, September 14, 2015
The exclusive rights for this product are applicable for the US, Canada, India, Russia and the CIS, Australia, New Zealand and Venezuela.


BT Online Bureau
New Delhi, July 30, 2015
The firm posted operating profit of Rs 771 crore in the reporting quarter against Rs 647 crore in the Q1 of last fiscal.


PTI
New Delhi, June 19, 2015
With regard to acquisition of select portfolio of the established products business of UCB in India, Dr Reddy's Laboratories has concluded the transaction, the company said in a filing to the BSE.


E. Kumar Sharma
January 27, 2015
The 270-page book is an anecdotal account of the way Dr K Anji Reddy, founder of Dr Reddy's Labs, who many regard as a pioneer in Indian pharma industry, saw his company and the industry evolve.


E. Kumar Sharma
December 5, 2014
At work, G.V. Prasad, Co-Chairman and CEO of Dr. Reddy's Labs can take both the wide-angle and the close-up view - different mentors taught him the value of each.


PTI
New Delhi, November 26, 2014
Ranbaxy Laboratories had sued US Food and Drug Administration (USFDA) over revoking an approval to sell generic versions of Nexium and Valcyte in the US market.


Zeba Siddiqui
Mumbai, November 18, 2014
The FDA told Ranbaxy that its decision to grant approvals for both the drugs were \"in error\", after it found that Ranbaxy's plants did not meet its quality standards.


Zeba Siddiqui
Mumbai, November 12, 2014
Leading generic drugmakers Dr Reddy's Labs and Glenmark Pharma in November posted a drop in their second-quarter US sales, blaming the slowdown in the approval process.


E Kumar Sharma
November 7, 2014
The FDA has also denied Ranbaxy 180-day marketing exclusivity for a generic version of Roche's antiviral drug Valcyte, according to a company statement on Thursday.


Zeba Siddiqui
Mumbai, November 7, 2014
The move comes after Ranbaxy Labs said on Thursday that FDA had stripped the company of its tentative approval to launch the first copy of the drug due to quality control issues at its plants.


E Kumar Sharma
November 8, 2014
Sentiss manufactures almost all its products in-house in India. Ophthalmic products make for almost 95 per cent of its total sales.


PTI
Mumbai, October 22, 2014
With markets ending positively on last day of the Hindu Samvat year 2070, the Sensex has risen by over 26 per cent during this period.


Zeba Siddiqui
Mumbai, August 21, 2014
In a US stock exchange filing this week, Dr Reddy's said the Consumer Product Safety Commission planned to seek civil penalties against the company for allegedly violating rules intended to prevent children from ingesting harmful substances.


E. Kumar Sharma
July 2, 2014
Given the optimistic mood in the country about the reform process, Satish Reddy, President of the Indian Pharmaceutical Alliance (IPA) and Chairman at Dr Reddy's Labs, said that \"the industry will be looking for signals of revival of the growth story\".


PTI
Hyderabad, June 27, 2014
Drug maker Dr Reddy's Laboratories has launched duloxetine delayed-release capsules USP 20 mg, 30 mg and 60 mg in the US market, the company said.


PAGES 1 OF 2  12